Mydriatic solution for outpatient indirect ophthalmoscopy

Area of Science:

• Ophthalmology
• Pharmacology

Background:

• Effective mydriasis is crucial for outpatient indirect ophthalmoscopy.
• Ideal mydriatic agents should offer rapid, significant, and temporary pupil dilation.
• Minimizing cycloplegia and systemic side effects is a key consideration.

Purpose of the Study:

• To evaluate the efficacy of tropicamide and phenylephrine hydrochloride combinations for mydriasis.
• To determine optimal concentrations for achieving adequate pupil dilation in a diverse patient population.

Main Methods:

• Assessing pupil dilation percentage, degree, and resistance to light.
• Testing various concentrations of tropicamide and phenylephrine hydrochloride.
• Evaluating efficacy in a general retina clinic population, including those with dark irides and on miotic therapy.

Main Results:

• A solution of 0.8% tropicamide with 5% phenylephrine hydrochloride achieved 98.8% adequate pupil dilation.
• Reduced concentrations of either drug resulted in less effective mydriasis.
• Higher tropicamide concentrations led to precipitation and reduced dilation efficacy.

Conclusions:

• The combination of 0.8% tropicamide and 5% phenylephrine hydrochloride is an effective mydriatic agent.
• A single drop provides adequate dilation for most patients; two drops may offer enhanced effect.
• This formulation balances efficacy with minimal adverse effects for ophthalmic procedures.